Please login to the form below

Not currently logged in
Email:
Password:

business model

This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

Her comments in turn sparked a heated debate on social media, with many from within the sector rushing to defend its motives and its business model.

Latest news

  • Axovant drops last ‘legacy’ drug to focus on gene therapies Axovant drops last ‘legacy’ drug to focus on gene therapies

    s original business model of licensing dormant drugs from other developers and re-purposing them for new uses.

  • Generic Differentiation Generic Differentiation

    In my conversations and research interviews with executives in this part of our market, the (singular) generic business model used to be taken as fact. ... To a Darwinian, that seems an unlikely prediction and, sure enough, we’re seeing emerging

  • The Midas Touch The Midas Touch

    Using this idea – that business-model innovation is all about optimising risk-adjusted return on investment – opens up a new way of thinking about how the industry is evolving. ... to myopically focus on the big bet, big risk, big pay-off business

  • Artificial intelligence in healthcare Artificial intelligence in healthcare

    Just a few weeks ago, for example, UK-based Sensyne Health made its debut on the AIM, raising £60m to advance a business model based on sifting through anonymised NHS data

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    This is understandable but flawed, for at least two reasons. Firstly, it assumes that such firms have a single business model to copy, when in fact they are coalitions of businesses ... This is another example, after divesting itself of its respiratory

More from news
Approximately 1 fully matching, plus 217 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward. " />. ... Pharma has recognised the need to change its traditional business model and explore more collaborative ways of working.

  • Trust me, I’m from pharma Trust me, I’m from pharma

    This will ultimately require an authentic customer-centred approach and the widespread redefinition of the old pharma business model. ... Companies, says Cath, should focus on how they can change their business model to become better, rather than

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    In April this year, a Goldman Sachs biotech report suggested that curing patients, as many gene therapies promise to, is not a good business model. ... Cell and gene therapies undoubtedly do pose difficult questions – but there is also no question of

  • How can pharma build bridges with HCPs online? How can pharma build bridges with HCPs online?

    Thanks to a unique agreement with NHS trusts, Fendix enables organisations to use NHS intranets to host content to provide information and educational value for HCPs.  This business model not only

  • Deal Watch January 2018

    Spin-outs don't always last long as independent companies. In our recent annual deal review for 2017 we highlighted how the spin-out business model is alive and kicking and

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14

  • Galenica Group strengthens management team Galenica Group strengthens management team

    We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking

  • Moderna Therapeutics appoints chief business officer Moderna Therapeutics appoints chief business officer

    Saqib Islam brings experience from Alexion Pharmaceuticals. Cambridge, Massachusetts-based Moderna Therapeutics has appointed Saqib Islam as its new chief business officer from 9 May. ... Islam said: “Already a clinical stage company, Moderna has

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics